Wells Fargo’s Korro Bio KRRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$24.5K Sell
2,469
-7,095
-74% -$87.4K ﹤0.01% 5822
2026
Q2
$126K Buy
9,564
+6,975
+269% +$86.7K ﹤0.01% 5436
2026
Q1
$29.3K Sell
2,589
-4,933
-66% -$54.3K ﹤0.01% 5641
2025
Q4
$60.3K Buy
7,522
+2,352
+45% +$55K ﹤0.01% 5532
2025
Q3
$248K Buy
5,170
+837
+19% +$18.6K ﹤0.01% 4811
2025
Q2
$54.1K Buy
4,333
+540
+14% +$7.78K ﹤0.01% 5480
2025
Q1
$66K Buy
3,793
+401
+12% +$11.9K ﹤0.01% 5297
2024
Q4
$129K Buy
3,392
+831
+32% +$42.7K ﹤0.01% 5054
2024
Q3
$85.6K Buy
2,561
+68
+3% +$2.86K ﹤0.01% 5109
2024
Q2
$84.4K Buy
2,493
+2,444
+4,988% +$135K ﹤0.01% 5039
2024
Q1
$4.41K Buy
49
+1
+2% +$55 ﹤0.01% 5913
2023
Q4
$2.3K Buy
48
+36
+300% +$1.19K ﹤0.01% 6081
2023
Q3
$228 Hold
12
– – ﹤0.01% 6554
2023
Q2
$210 Hold
12
– – ﹤0.01% 6688
2023
Q1
$299 Hold
12
– – ﹤0.01% 6666
2022
Q4
$2.27K Hold
12
– – ﹤0.01% 5981
2022
Q3
$1K Buy
12
+1
+9% +$102 ﹤0.01% 6377
2022
Q2
$1K Sell
11
-65
-86% -$4.39K ﹤0.01% 6538
2022
Q1
$8K Sell
76
-224
-75% -$42.8K ﹤0.01% 6344
2021
Q4
$77K Buy
300
+293
+4,186% +$89.1K ﹤0.01% 5763
2021
Q3
$2K Sell
7
-307
-98% -$121K ﹤0.01% 6577
2021
Q2
$156K Sell
314
-136
-30% -$66.4K ﹤0.01% 5133
2021
Q1
$213K Sell
450
-722
-62% -$1.4M ﹤0.01% 5126
2020
Q4
$2.06M Buy
1,172
+78
+7% +$103K ﹤0.01% 3475
2020
Q3
$1.05M Buy
1,094
+11
+1% +$11.8K ﹤0.01% 3820
2020
Q2
$1.26M Buy
1,083
+984
+994% +$889K ﹤0.01% 3632
2020
Q1
$88K Buy
99
+83
+519% +$89.6K ﹤0.01% 5126
2019
Q4
$14K Buy
+16
New +$12.4K ﹤0.01% 5818

Other funds holding KRRO

Wells Fargo's KRRO Position: Q3 2026 in Review

Wells Fargo reduced its Korro Bio (KRRO) stake by 74% in Q3 2026, selling an estimated $87.4K and leaving 2,469 shares worth $24.5K. The position accounts for ﹤0.01% of the portfolio, ranked #5822.

Wells Fargo first reported a position in KRRO in Q4 2019 and has held it in 28 quarters since. The position peaked at $2.06M in Q4 2020. 105 funds tracked by Wall St. Rank hold KRRO as of Q3 2026.

  • Wells Fargo held 2,469 shares of Korro Bio worth $24.5K as of Q3 2026.
  • Wells Fargo sold 7,095 Korro Bio shares in Q3 2026, an estimated $87.4K.
  • Korro Bio made up ﹤0.01% of Wells Fargo's portfolio in Q3 2026, its #5822 holding.
  • Wells Fargo first reported a position in Korro Bio in Q4 2019 and has held it in 28 quarters since.
  • Wells Fargo's Korro Bio position peaked at $2.06M in Q4 2020.
  • 105 funds tracked by Wall St. Rank held Korro Bio as of Q3 2026.

Based on Wells Fargo's 13F filing for Q3 2026, filed 16 Nov 2026.